INDERM

This brand name is authorized in Ecuador, Germany, Netherlands.

Active ingredients

The drug INDERM contains one active pharmaceutical ingredient (API):

1	Erythromycin UNII 63937KV33D - ERYTHROMYCIN
	Erythromycin exerts its antimicrobial action by binding to the 50S ribosomal sub-unit of susceptible microorganisms and suppresses protein synthesis. Erythromycin is bacteriostatic and bactericidal depending on its concentration and the type of organism.
	Read more about Erythromycin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D10AF02	Erythromycin	D Dermatologicals → D10 Anti-acne preparations → D10A Anti-acne preparations for topical use → D10AF Antiinfectives for treatment of acne
Discover more medicines within D10AF02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	03239575
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	28618-10-08
NL	Z-Index G-Standaard	13557920
NL	Z-Index G-Standaard, PRK	72362